RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 113.3305

Change

0.00 (0.00)%

Market Cap

N/A

Volume

595.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-21 )

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
EUSC WisdomTree Europe Hedged .. 2.59 % 0.58 %

N/A

USD 0.05B
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

N/A

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

N/A

USD 9.22B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.24B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

N/A

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.99% 60% D- 86% B+
Dividend Return 0.57% 31% F 11% F
Total Return 24.56% 61% D- 84% B
Trailing 12 Months  
Capital Gain 33.85% 32% F 82% B
Dividend Return 0.81% 24% F 9% A-
Total Return 34.66% 32% F 80% B-
Trailing 5 Years  
Capital Gain 122.00% 80% B- 89% A-
Dividend Return 2.36% 40% F 7% C-
Total Return 124.36% 80% B- 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.47% 40% F 79% B-
Dividend Return 15.69% 39% F 76% C+
Total Return 0.22% 21% F 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 27.12% 96% N/A 38% F
Risk Adjusted Return 57.84% 93% A 75% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.